与使用5α-减少酶抑制剂相关的诉讼:加拿大法律数据库审查
David-Dan Nguyen1, Massine Fellouah2, Anna-Lisa V Nguyen3
1Division of Urology, University of Toronto, Toronto, Ontario, Canada.
The Canadian journal of urology
|June 21, 2023
概括
加拿大关于5α-减少酶抑制剂 (5ARIs) 的诉讼主要涉及持续性勃起功能障碍. 这些案件,通常是针对男性模式脱发治疗的集体诉讼,仍在进行中,尚未发布任何判决.
科学领域:
- 药理学 药理学是指药理学的学科.
- 法律医学 法律医学
- 皮肤病学 皮肤病学
背景情况:
- 5α-减少酶抑制剂 (5ARIs) 是一种被广泛处方的药物.
- 关于与5ARI使用相关的不良事件存在争议.
- 描述与5ARI并发症相关的法律行动至关重要.
研究的目的:
- 分析加拿大的诉讼,涉及因使用5α-减少酶抑制剂 (5ARI) 引起的医学并发症.
- 确定与5ARIs相关的不良事件和法律索赔的性质.
主要方法:
- 使用CanLII.II进行了对法律案件的全面搜索.
- 包括涉及5ARI用户声称出现不良事件的病例.
- 法律专家协助提取相关案件特征.
主要成果:
- 2013年12月至2019年2月的12份法律文件符合纳入标准,代表了3个不同的案例.
- 所有投诉 (n=3) 都引用了药物的副作用,特别是停药后持续性勃起功能障碍.
- 处方仅限于男性发型脱发;所有案件都是正在进行的集体诉讼.
结论:
- 加拿大关于5ARI相关性副作用的诉讼有限.
- 持续性功能障碍是确定的法律诉讼中唯一的投诉.
- 没有针对医生或制药公司的判决记录;案件仍在等待.
相关概念视频
Pharmacovigilance
908
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
908
Disorders of the Male Reproductive System
474
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
474
Antihypertensive Drugs: Direct Renin Inhibitors
704
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
704
Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
197
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
197
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148


